Cited by 2,712Cancer-related Molecular PathwaysSignaling Pathways in DiseasePI3K/AKT/mTOR signaling in cancer

The DOI matches its Crossref record; 234 of the 236 references it cites were found in a registry or an index.

p21 in cancer: intricate networks and multiple activities

Open access

Abbas, Tarek, Dutta, Anindya·2009·Nature Reviews Cancer

Open this paper in CoChat — free account

Abstract

One of the main engines that drives cellular transformation is the loss of proper control of the mammalian cell cycle. The cyclin-dependent kinase inhibitor p21 (also known as p21WAF1/Cip1) promotes cell cycle arrest in response to many stimuli. It is well positioned to function as both a sensor and an effector of multiple anti-proliferative signals. This Review focuses on recent advances in our understanding of the regulation of p21 and its biological functions with emphasis on its p53-independent tumour suppressor activities and paradoxical tumour-promoting activities, and their implications in cancer.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nrc2657

Cites

234 of 234 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Cell cycle, CDKs and cancer: a changing paradigm
Malumbres, M., & Barbacid, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2602 · Cited by 3,957 · cited 1×
“CDK1, at least in some tissues, may be the crucial target of p21 in tumorigenesi”
Background
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
Tumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051
Hepatogastroenterology
Xu, X., Yuan, G., Li, Q., Shan, S.-L., & Jiang, S. (2012) · Hepatogastroenterology · doi:10.5754/hge12404 · Cited by 1,825
Restoration of p53 function leads to tumour regression in vivo
Ventura, A., Kirsch, D. G., McLaughlin, M. E., Tuveson, D. A., Grimm, J., Lintault, L., Newman, J., Reczek, E. E., Weissleder, R., & Jacks, T. (2007) · Nature · doi:10.1038/nature05541 · Cited by 1,820 · cited 1×
“Recent work suggests that tumour regression can be achieved through the reactivation of senescence, for example by restoring p53 functio”
Background
PCNA, the Maestro of the Replication Fork
Moldovan, G.-L., Pfander, B., & Jentsch, S. (2007) · Cell · doi:10.1016/j.cell.2007.05.003 · Cited by 1,796
Cellular senescence in cancer and aging.
Collado, M., Blasco, M. A., & Serrano, M. (2007) · Cell · doi:10.1016/j.cell.2007.07.003 · Cited by 1,708

Flagged first, then by citations

Show all 236 references

2 of the 236 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

Martin-Caballero, J., Flores, J. M., Garcia-Palencia, P. & Serrano, M. Tumor susceptibility of p21Waf1/Cip1-deficient mice. Cancer Res. 61, 6234–6238 (2001). This study demonstrates that deletion of Cdkn1a in mice results in spontaneous tumours but with late onset.

Sorted by citations

Items 501–600 of 1,005

Sorting nexin 10 acts as a tumor suppressor in tumorigenesis and progression of colorectal cancer through regulating chaperone mediated autophagy degradation of p21Cip1/WAF1
Zhang, S., Hu, B., You, Y., Yang, Z., Liu, L., Tang, H., Bao, W., Guan, Y., & Shen, X. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.045 · Cited by 54
Chemotherapy-driven increases in the CDKN1A/PTN/PTPRZ1 axis promote chemoresistance by activating the NF-κB pathway in breast cancer cells
Huang, P. F., Ouyang, D., Chang, S., Li, M., Li, L., Li, Q.-Y., Zeng, R., Zou, Q., Su, J., Zhao, P., et al. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0304-4 · Cited by 54
Radiation-Induced DNMT3B Promotes Radioresistance in Nasopharyngeal Carcinoma through Methylation of p53 and p21
Wu, C., Guo, E., Ming, J., Sun, W., Nie, X., Sun, L., Peng, S., Luo, M., Liu, D., Zhang, L., et al. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.04.007 · Cited by 54
Furazans in Medicinal Chemistry
Mancini, R. S., Barden, C., Weaver, D. F., & Reed, M. A. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01901 · Cited by 55
Antisense-miR-21 enhances differentiation/apoptosis and reduces cancer stemness state on anaplastic thyroid cancer
Haghpanah, V., Fallah, P., Tavakoli, R., Naderi, M., Samimi, H., Soleimani, M., & Larijani, B. A. (2015) · Tumor Biology · doi:10.1007/s13277-015-3923-z · Cited by 54
MicroRNA-92a Promotes Cell Proliferation in Cervical Cancer via Inhibiting p21 Expression and Promoting Cell Cycle Progression
Su, Z., Yang, H., Zhao, M., Wang, Y., Deng, G., & Chen, R. (2017) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504016x14732772150262 · Cited by 53
Retracted
Unveiling the potential effects of resveratrol in lung cancer treatment: Mechanisms and nanoparticle-based drug delivery strategies
Najafiyan, B., Hosseini, Z. B., Esmaelian, S., Firuzpour, F., Anaraki, S. R., Kalantari, L., Hheidari, A., Mesgari, H., & Nabi‐Afjadi, M. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116207 · Cited by 54
Quinoline-based clioquinol and nitroxoline exhibit anticancer activity inducing FoxM1 inhibition in cholangiocarcinoma cells
Prachayasittikul, V., Chan-on, W., Nguyen, H., Songtawee, N., Suwanjang, W., & Prachayasittikul, S. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s79313 · Cited by 53
Deficient DNA Damage Response and Cell Cycle Checkpoints Lead to Accumulation of Point Mutations in Human Embryonic Stem Cells
Hyka‐Nouspikel, N., Desmarais, J. A., Gokhale, P. J., Jones, M., Meuth, M., Andrews, P. W., & Nouspikel, T. P. (2012) · Stem Cells · doi:10.1002/stem.1177 · Cited by 52
p53 Regulates the Neuronal Intrinsic and Extrinsic Responses Affecting the Recovery of Motor Function following Spinal Cord Injury
Floriddia, E. M., Rathore, K. I., Tedeschi, A., Quadrato, G., Wuttke, A., Lueckmann, J.-M., Kigerl, K. A., Popovich, P. G., & Giovanni, S. D. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1925-12.2012 · Cited by 51
Decreased nuclear expression and increased cytoplasmic expression of ING5 may be linked to tumorigenesis and progression in human head and neck squamous cell carcinoma
Li, X., Nishida, T., Noguchi, A., Yang, Z., Takahashi, H., Yang, X.-H., Masuda, S., & Takano, Y. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0815-x · Cited by 53
Recapitulating tumour microenvironment in chitosan–gelatin three-dimensional scaffolds: an improvedin vitrotumour model
Arya, N., Sardana, V., Saxena, M. T., Rangarajan, A., & Katti, D. S. (2012) · Journal of The Royal Society Interface · doi:10.1098/rsif.2012.0564 · Cited by 53
Antibiotic drug tigecycline inhibits melanoma progression and metastasis in a p21CIP1/Waf1-dependent manner
Hu, H., Dong, Z., Tan, P., Zhang, Y., Liu, L., Yang, L., Liu, Y., & Cui, H. (2015) · Oncotarget · doi:10.18632/oncotarget.6419 · Cited by 52
Long noncoding RNA LUNAR1 associates with cell proliferation and predicts a poor prognosis in diffuse large B-cell lymphoma
Peng, W., & Feng, J. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.12.001 · Cited by 53
Osthole Induces Cell Cycle Arrest and Inhibits Migration and Invasion via PTEN/Akt Pathways in Osteosarcoma
Wang, L., Lei, Y., Lu, Y., Chen, Y., Liu, T., Peng, Y., Zhou, Y., Cao, Y., Bi, Z., Liu, T., et al. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000445573 · Cited by 53
Berry anthocyanins reduce proliferation of human colorectal carcinoma cells by inducing caspase-3 activation and p21 upregulation
Anwar, S., Fratantonio, D., Ferrari, D., Saija, A., Cimino, F., & Speciale, A. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5397 · Cited by 53
The Role of Cell Cycle Regulators in Cell Survival—Dual Functions of Cyclin-Dependent Kinase 20 and p21Cip1/Waf1
Lai, L., Shin, G. Y., & Qiu, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228504 · Cited by 53
Enhanced anticancer efficiency of doxorubicin against human glioma by natural borneol through triggering ROS-mediated signal
Cao, W.-Q., Li, Y., Hou, Y., Yang, M., Fu, X., Zhao, B., Jiang, H., & Fu, X. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109261 · Cited by 52
Epstein–Barr virus-encoded small non-coding RNAs induce cancer cell chemoresistance and migration
Banerjee, A. S., Pal, A. D., & Banerjee, S. (2013) · Virology · doi:10.1016/j.virol.2013.05.020 · Cited by 52
TRIM39 regulates cell cycle progression and DNA damage responses via stabilizing p21
Zhang, L., Mei, Y., Fu, N. Y., Guan, L., Xie, W. D., Liu, H., Yu, C., Yin, Z., Yu, V. C. K., & You, H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214156110 · Cited by 52
Mechanisms of Mycotoxin-induced Dermal Toxicity and Tumorigenesis Through Oxidative Stress-related Pathways
Doi, K., & Uetsuka, K. (2014) · Journal of Toxicologic Pathology · doi:10.1293/tox.2013-0062 · Cited by 52
Regulation of p21/CIP1/WAF-1 mediated cell-cycle arrest by RNase L and tristetraprolin, and involvement of AU-rich elements
Al‐Haj, L., Blackshear, P. J., & Khabar, K. S. A. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks545 · Cited by 53
EBNA3C Augments Pim-1 Mediated Phosphorylation and Degradation of p21 to Promote B-Cell Proliferation
Banerjee, S., Lu, J. L., Cai, Q., Sun, Z., Jha, H. C., & Robertson, E. S. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004304 · Cited by 51
Human rpL3 plays a crucial role in cell response to nucleolar stress induced by 5-FU and L-OHP
Esposito, D., Crescenzi, E., Sagar, V., Loreni, F., Russo, A., & Russo, G. (2014) · Oncotarget · doi:10.18632/oncotarget.2591 · Cited by 52
Danusertib Induces Apoptosis, Cell Cycle Arrest, and Autophagy but Inhibits Epithelial to Mesenchymal Transition Involving PI3K/Akt/mTOR Signaling Pathway in Human Ovarian Cancer Cells
Zi, D., Zhou, Z.-W., Yang, Y.-J., Huang, L., Zhou, Z.-L., He, S.-M., He, Z.-X., & Zhou, S.-F. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161126018 · Cited by 52
LincRNA-p21 predicts favorable clinical outcome and impairs tumorigenesis in diffuse large B cell lymphoma patients treated with R-CHOP chemotherapy
Peng, W., Wu, J., & Feng, J. (2015) · Clinical and Experimental Medicine · doi:10.1007/s10238-015-0396-8 · Cited by 52
MicroRNA-16 mediates the regulation of a senescence–apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas
Kitadate, A., Ikeda, S., Teshima, K., Ito, M., Toyota, I., Hasunuma, N., Takahashi, N., Miyagaki, T., Sugaya, M., & Tagawa, H. (2015) · Oncogene · doi:10.1038/onc.2015.435 · Cited by 53
The BET bromodomain inhibitor JQ1 radiosensitizes non-small cell lung cancer cells by upregulating p21
Wang, J., Wang, Y., Mei, H., Yin, Z., Geng, Y., Zhang, T., Wu, G., & Lin, Z. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.01.031 · Cited by 52
Theabrownin Inhibits Cell Cycle Progression and Tumor Growth of Lung Carcinoma through c-myc-Related Mechanism
Zhou, L., Wu, F., Jin, W., Yan, B., Chen, X., He, Y., Yang, W., Du, W., Zhang, Q., Guo, Y., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00075 · Cited by 52
Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer
James, N. E., Chichester, C. O., & Ribeiro, J. R. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00124 · Cited by 52
The role of p21waf1/cip1 and p27Kip1 in HDACi-mediated tumor cell death and cell cycle arrest in the Eμ-myc model of B-cell lymphoma
Newbold, A., Salmon, J. M., Martin, B. P., Stanley, K., & Johnstone, R. W. (2013) · Oncogene · doi:10.1038/onc.2013.482 · Cited by 51
The long noncoding RNA HOXA transcript at the distal tip promotes colorectal cancer growth partially via silencing of p21 expression
Lian, Y., Ding, J., Zhang, Z., Shi, Y., Zhu, Y., Li, J., Peng, P., Wang, J., Fan, Y., De, W., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-4617-2 · Cited by 51
Biguanides drugs: Past success stories and promising future for drug discovery
Grytsai, O., Myrgorodska, I., Rocchi, S., Ronco, C., & Benhida, R. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113726 · Cited by 51
Chlorogenic acid induces apoptosis and cell-cycle arrest in colorectal cancer cells
Ranjbary, A. G., Bagherzadeh, A., Sabbaghi, S. S., Faghihi, A., Karimi, D. N., Naji, S., & Kardani, M. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08854-y · Cited by 47
The role and mechanism of NAT10‐mediated ac4C modification in tumor development and progression
Gu, Z., Zou, L., Pan, X., Yu, Y., Liu, Y., Zhang, Z., Liu, J., Mao, S., Zhang, J., Guo, C., et al. (2024) · MedComm · doi:10.1002/mco2.70026 · Cited by 52
MicroRNA-10b inhibition reduces E2F1-mediated transcription and miR-15/16 activity in glioblastoma
Teplyuk, N. M., Uhlmann, E. J., Wong, H. K., Karmali, P. P., Basu-Shrivastava, M., Gabriely, G., Jain, A. K., Wang, Y., Chiocca, E. A., Stephens, R. M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3009 · Cited by 52
Association between Variations in Cell Cycle Genes and Idiopathic Pulmonary Fibrosis
Korthagen, N. M., van Moorsel, C. H. M., Barlo, N. P., Kazemier, K. M., Ruven, H. J. T., & Grutters, J. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030442 · Cited by 51
Interferon-Lambda as a Potential Therapeutic Agent in Cancer Treatment
Steen, H. C., & Gamero, A. M. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0058 · Cited by 51
Gene Profiling Reveals a Role for Stress Hormones in the Molecular and Behavioral Response to Food Restriction
Guarnieri, D. J., Brayton, C. E., Richards, S., Maldonado‐Avilés, J. G., Trinko, R., Nelson, J. C., Taylor, J. R., Gourley, S. L., & Dileone, R. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.06.028 · Cited by 52
Inhibition of Epidermal Growth Factor Receptor Signaling by Saussurea involucrata, a Rare Traditional Chinese Medicinal Herb, in Human Hormone-Resistant Prostate Cancer PC-3 Cells
Way, T., Lee, J., Kuo, D., Fan, L., Huang, C., Lin, H., Shieh, P., Kuo, P.-T., Liao, C.-F., Liu, H., et al. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf903793p · Cited by 51
Apoptosis Induced by Piroxicam plus Cisplatin Combined Treatment Is Triggered by p21 in Mesothelioma
Baldi, A., Piccolo, M. T., Boccellino, M., Donizetti, A., Cardillo, I., Porta, R. L., Quagliuolo, L., Spugnini, E. P., Cordero, F., Citro, G., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023569 · Cited by 51
Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities
Möllgård, L., Saft, L., Treppendahl, M. B., Dybedal, I., Nørgaard, J. M., Astermark, J., Ejerblad, E., Garelius, H. G., Dufva, I. H., Jansson, M., et al. (2011) · Haematologica · doi:10.3324/haematol.2010.039669 · Cited by 51
Knockdown of STEAP1 inhibits cell growth and induces apoptosis in LNCaP prostate cancer cells counteracting the effect of androgens
Gomes, I. M., Rocha, S. M., Gaspar, C., Alvelos, M. I., Santos, C. R., Socorro, S., & Maia, C. J. (2018) · Medical Oncology · doi:10.1007/s12032-018-1100-0 · Cited by 51
LncRNA HOTAIR/miR‐613/c‐met axis modulated epithelial‐mesenchymal transition of retinoblastoma cells
Yang, G., Fu, Y., Lu, X., Wang, M., Dong, H., & Li, Q. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13796 · Cited by 51
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth
Parrish, J. K., McCann, T. S., Sechler, M., Sobral, L. M., Ren, W., Jones, K. L., Tan, A. C., & Jedlicka, P. (2018) · Oncotarget · doi:10.18632/oncotarget.26011 · Cited by 51
NFIB promotes cell survival by directly suppressing p21 transcription in TP53‐mutated triple‐negative breast cancer
Liu, R., Vo, T. M., Jain, S., Choi, W., Garcia, E. P., Monckton, E. A., Mackey, J. R., & Godbout, R. (2018) · The Journal of Pathology · doi:10.1002/path.5182 · Cited by 51
Transcriptional response to Wnt activation regulates the regenerative capacity of the mammalian cochlea
Samarajeewa, A., Lenz, D. R., Xie, L., Chiang, H., Kirchner, R., Mulvaney, J. F., Edge, A. S. B., & Dabdoub, A. (2018) · Development · doi:10.1242/dev.166579 · Cited by 49
N-myc downstream-regulated gene 1 inhibits the proliferation of colorectal cancer through emulative antagonizing NEDD4-mediated ubiquitylation of p21
Zhang, S., Yu, C., Yang, X. Y., Hong, H., Lu, J., Hu, W., Hao, X., Li, S., Aikemu, B., Yang, G., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1476-5 · Cited by 51
DPP3/CDK1 contributes to the progression of colorectal cancer through regulating cell proliferation, cell apoptosis, and cell migration
Tong, Y., Huang, Y., Zhang, Y., Zeng, X., Yan, M., Xia, Z., & Lai, D. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03796-4 · Cited by 51
Molecular hybridization design and synthesis of novel spirooxindole-based MDM2 inhibitors endowed with BCL2 signaling attenuation; a step towards the next generation p53 activators
Lotfy, G., Aziz, Y. M. A., Said, M. M., Ashry, E. S. H. E., Tamany, E. S. H. E., Abu-Serie, M. M., Teleb, M., Dömling, A. S. S., & Barakat, A. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105427 · Cited by 50
m6A demethylase ALKBH5 promotes proliferation of esophageal squamous cell carcinoma associated with poor prognosis
Nagaki, Y., Motoyama, S., Yamaguchi, T., Hoshizaki, M., Sato, Y., Sato, T., Koizumi, Y., Wakita, A., Kawakita, Y., Imai, K., et al. (2020) · Genes to Cells · doi:10.1111/gtc.12792 · Cited by 50
Refinement of a differentiation protocol using neuroblastoma SH-SY5Y cells for use in neurotoxicology research
Simões, R. F., Ferrão, R., Silva, M. R., Pinho, S. L. C., Ferreira, L., Oliveira, P. J., & Cunha‐Oliveira, T. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.111967 · Cited by 50
p16INK4Aand p14ARFTumor Suppressor Pathways Are Deregulated in Malignant Rhabdoid Tumors
Venneti, S., Le, P., Martínez, D., Eaton, K. W., Shyam, N., Jordan‐Sciutto, K. L., Pawel, B., Biegel, J. A., & Judkins, A. R. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31822146ca · Cited by 50
A Myc–microRNA network promotes exit from quiescence by suppressing the interferon response and cell-cycle arrest genes
Polioudakis, D., Bhinge, A., Killion, P. J., Lee, B., Abell, N. S., & Iyer, V. R. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks1452 · Cited by 50
Novel Irreversible Small Molecule Inhibitors of Replication Protein A Display Single-Agent Activity and Synergize with Cisplatin
Neher, T. M., Bodenmiller, D. M., Fitch, R. W., Jalal, S. I., & Turchi, J. J. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0303 · Cited by 53
Inhibitory Effects of Metabolites of 5-Demethylnobiletin on Human Nonsmall Cell Lung Cancer Cells
Song, M., Charoensinphon, N., Wu, X., Zheng, J., Gao, Z., Xu, F., Wang, M., & Xiao, H. (2016) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6b01367 · Cited by 50
Stabilization of p21 by mTORC1/4E-BP1 predicts clinical outcome of head and neck cancers
Llanos, S., Garcia-Pedrero, J. M., Morgado-Palacin, L., Rodrigo, J. P., & Serrano, M. (2016) · Nature Communications · doi:10.1038/ncomms10438 · Cited by 52
Long non-coding RNA UCA1 promotes gallbladder cancer progression by epigenetically repressing p21 and E-cadherin expression
Cai, Q., Jin, L., Wang, S., Zhou, D., Wang, J., Tang, Z., & Quan, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.18204 · Cited by 49
p53-independent p21 induction by MELK inhibition
Matsuda, T., Kato, T., Kiyotani, K., Tarhan, Y. E., Saloura, V., Chung, S., Ueda, K., Nakamura, Y., & Park, J.-H. (2017) · Oncotarget · doi:10.18632/oncotarget.18488 · Cited by 52
Camptothecin induces G2/M phase arrest through the ATM-Chk2-Cdc25C axis as a result of autophagy-induced cytoprotection: Implications of reactive oxygen species
Jayasooriya, R. G. P. T., Dilshara, M. G., Molagoda, I. M. N., Park, C., Park, S. R., Lee, S., Choi, Y. H., & Kim, G. (2018) · Oncotarget · doi:10.18632/oncotarget.24934 · Cited by 53
Nucleoporin Nup155 is part of the p53 network in liver cancer
Hölzer, K., Ori‬‬, A., Cooke, A. M., Dauch, D., Drucker, E., Riemenschneider, P., Andrés‐Pons, A., DiGuilio, A. L., Mackmull, M., Baßler, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10133-z · Cited by 53
A KRAS-responsive long non-coding RNA controls microRNA processing
Shi, L., Magee, P., Fassan, M., Sahoo, S., Leong, H. S., Lee, D. C. H., Sellers, R., Brullé, L., Cairo, S., Monteverde, T., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22337-3 · Cited by 50
Phenformin Induces Cell Cycle Change, Apoptosis, and Mesenchymal-Epithelial Transition and Regulates the AMPK/mTOR/p70s6k and MAPK/ERK Pathways in Breast Cancer Cells
Liu, Z., Ren, L., Liu, C., Xia, T., Zha, X., & Wang, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131207 · Cited by 50
SIRT1 regulates trophoblast senescence in premature placental aging in preeclampsia
Wang, Y., Zhang, Y., Wu, Y., He, Y., Xiang, J., Huang, J., Lash, G. E., & Li, P. (2022) · Placenta · doi:10.1016/j.placenta.2022.04.001 · Cited by 49
Adaptive translational pausing is a hallmark of the cellular response to severe environmental stress
Jobava, R., Mao, Y., Guan, B., Hu, D., Krokowski, D., Chen, C.-W., Shu, X. E., Chukwurah, E., Wu, J., Gao, Z., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.09.029 · Cited by 49
MDM2, MDMX, and p73 regulate cell-cycle progression in the absence of wild-type p53
Klein, A. M., Biderman, L., Tong, D., Alaghebandan, B., Plumber, S. A., Mueller, H. S., van Vlimmeren, A. E., Katz, C., & Prives, C. L. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2102420118 · Cited by 48
Cyproheptadine, an antihistaminic drug, inhibits proliferation of hepatocellular carcinoma cells by blocking cell cycle progression through the activation of P38 MAP kinase
Feng, Y., Feng, C.-W., Chen, S.-Y., Hsieh, H., Chen, Y., & Hsu, C. (2015) · BMC Cancer · doi:10.1186/s12885-015-1137-9 · Cited by 49
Dux4 induces cell cycle arrest at G1 phase through upregulation of p21 expression
Xu, H., Wang, Z., Jin, S., Hao, H.-J., Zheng, L., Zhou, B., Zhang, W., Lv, H., & Yuan, Y. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.02.105 · Cited by 50
Entinostat, a novel histone deacetylase inhibitor is active in B‐cell lymphoma and enhances the anti‐tumour activity of rituximab and chemotherapy agents
Frys, S., Simons, Z., Hu, Q., Barth, M. J., Gu, J. J., Mavis, C. K., Skitzki, J. J., Liu, S., Czuczman, M. S., & Hernandez‐Ilizaliturri, F. J. (2015) · British Journal of Haematology · doi:10.1111/bjh.13318 · Cited by 52
Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinoma
Yokoyama, M., Chiba, T., Zen, Y., Oshima, M., Kusakabe, Y., Noguchi, Y., Yuki, K., Koide, S., Tara, S., Saraya, A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15528 · Cited by 49
Integrin α6β4-Src-AKT signaling induces cellular senescence by counteracting apoptosis in irradiated tumor cells and tissues
Jung, S. H., Lee, M., Park, H. A., Lee, H., Kang, D., Hwang, H. J., Park, C., Yu, D., Jung, Y. R., Mi-Na, H. O. N. G., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0114-7 · Cited by 48
RTN4 Knockdown Dysregulates the AKT Pathway, Destabilizes the Cytoskeleton, and Enhances Paclitaxel-Induced Cytotoxicity in Cancers
Pathak, G. P., Shah, R., Kennedy, B. E., Murphy, J. P., Clements, D. R., Konda, P., Giacomantonio, M., Xu, Z., Schlaepfer, I. R., & Gujar, S. A. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.05.026 · Cited by 48
Ruthenium(II) salicylate complexes inducing ROS-mediated apoptosis by targeting thioredoxin reductase
Chen, J., Zhang, Y., Jie, X.-M., She, J., Dongye, G.-Z., Zhong, Y., Deng, Y., Wang, J., Guo, B.-Y., & Chen, L. (2019) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2019.01.011 · Cited by 49
A positive feedback circuit comprising p21 and HIF‐1α aggravates hypoxia‐induced radioresistance of glioblastoma by promoting Glut1/LDHA‐mediated glycolysis
Jin, X., Kuang, Y., Li, L., Li, H., Zhao, T., He, Y., Di, C., Kang, J. L., Yuan, L., Yu, B., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202101736r · Cited by 50
Protective effect of myokine IL-15 against H2O2-mediated oxidative stress in skeletal muscle cells
Li, F., Li, Y., Tang, Y., Lin, B., Kong, X., Oladele, O. A., & Yin, Y. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3665-9 · Cited by 48
Human telomerase is directly regulated by non-telomeric TRF2-G-quadruplex interaction
Sharma, S., Mukherjee, A. K., Roy, S. S., Bagri, S., Lier, S., Verma, M., Sengupta, A., Kumar, M., Nesse, G., Pandey, D. P., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109154 · Cited by 55
Kaempferol: A potential agent in the prevention of colorectal cancer
Nejabati, H. R., & Roshangar, L. (2022) · Physiological Reports · doi:10.14814/phy2.15488 · Cited by 48
Cyclin D1 degradation and p21 induction contribute to growth inhibition of colorectal cancer cells induced by epigallocatechin-3-gallate
Zhang, X., Min, K., Wimalasena, J., & Baek, S. J. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1276-1 · Cited by 47
Arsenite induced poly(ADP-ribosyl)ation of tumor suppressor P53 in human skin keratinocytes as a possible mechanism for carcinogenesis associated with arsenic exposure
Komissarova, E. V., & Rossman, T. G. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.12.014 · Cited by 48
EIF3D silencing suppresses renal cell carcinoma tumorigenesis via inducing G2/M arrest through downregulation of Cyclin B1/CDK1 signaling
Pan, X., Chen, L., Yi, H., Xu, D., Liu, X., Li, L., Huang, Y., Cui, L., Gan, S., YANG, Q.-W., et al. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3459 · Cited by 48
miR-6734 Up-Regulates p21 Gene Expression and Induces Cell Cycle Arrest and Apoptosis in Colon Cancer Cells
Kang, M. R., Park, K. H., Yang, J.-O., Lee, C. W., Oh, S. J., Yun, J., Lee, M. Y., Han, S., & Kang, J. S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160961 · Cited by 48
The role of IL-29 in immunity and cancer
Kelm, N. E., Zhu, Z., Ding, V. A., Xiao, H., Wakefield, M. R., Bai, Q., & Fang, Y. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.08.002 · Cited by 48
Decreased levels of baseline and drug-induced tubulin polymerisation are hallmarks of resistance to taxanes in ovarian cancer cells and are associated with epithelial-to-mesenchymal transition
Durán, G. E., Wang, Y. C., Moisan, F., Francisco, E. B., & Sikic, B. I. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.102 · Cited by 48
Hyperglycaemia-induced miR-301a promotes cell proliferation by repressing p21 and Smad4 in prostate cancer
Li, X., Li, J., Cai, Y., Peng, S., Wang, J., Xiao, Z., Wang, Y., Tao, Y., Li, J., Leng, Q., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.031 · Cited by 48
p21cip1/waf1 Coordinates Autophagy, Proliferation and Apoptosis in Response to Metabolic Stress
Manu, K. A., Cao, P. H. A., Chai, T. F., Casey, P. J., & Wang, M. (2019) · Cancers · doi:10.3390/cancers11081112 · Cited by 47
The importance of CDC27 in cancer: molecular pathology and clinical aspects
Kazemi‐Sefat, G. E., Keramatipour, M., Talebi, S., Kavousi, K., Sajed, R., Kazemi-Sefat, N. A., & Mousavizadeh‬, K. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01860-9 · Cited by 48
Non-redundant functions of H2A.Z.1 and H2A.Z.2 in chromosome segregation and cell cycle progression
Gil, R. S., de Castro, I. J., Amin, H. A., Spanos, C., Vinciotti, V., Rappsilber, J., Sisu, C., & Vagnarelli, P. (2021) · EMBO Reports · doi:10.15252/embr.202052061 · Cited by 47
Therapeutic effects of histone deacetylase inhibitors on kidney disease
Chun, P. (2017) · Archives of Pharmacal Research · doi:10.1007/s12272-017-0998-7 · Cited by 48
Functional genomics identifies new synergistic therapies for retinoblastoma
Aubry, A., Pearson, J. D., Huang, K., Livne‐Bar, I., Ahmad, M. A. E.-R., Madhavan, J., Khetan, V., Ketela, T., Brown, K. R., Yu, T., et al. (2020) · Oncogene · doi:10.1038/s41388-020-1372-7 · Cited by 45
FRMD3 inhibits the growth and metastasis of breast cancer through the ubiquitination-mediated degradation of vimentin and subsequent impairment of focal adhesion
Shao, W., Li, J., Piao, Q., Yao, X., Li, M., Wang, S., Song, Z., Sun, Y., Zheng, L., Wang, G., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05552-2 · Cited by 47
RIST: A potent new combination therapy for glioblastoma
Nonnenmacher, L., Westhoff, M., Fulda, S., Karpel‐Massler, G., Halatsch, M., Engelke, J., Simmet, T., Corbacioglu, S., & Debatin, K. (2014) · International Journal of Cancer · doi:10.1002/ijc.29138 · Cited by 47
Stabilization of p21 (Cip1/WAF1) following Tip60-dependent acetylation is required for p21-mediated DNA damage response
Lee, M.-S., Seo, J., Choi, D. Y., Lee, E.-W., Ko, A., Ha, N., Yoon, J., Lee, H. W., Kim, K. P., & Song, J. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.159 · Cited by 47
Arecoline downregulates levels of p21 and p27 through the reactive oxygen species/m TOR complex 1 pathway and may contribute to oral squamous cell carcinoma
Ji, W., Yang, S., Chen, J. Y., Cheng, Y., Lee, Y., Chiang, M., & Chen, H. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02294.x · Cited by 47
Aminoimidazole Carboxamide Ribonucleotide (AICAR) Inhibits the Growth of Retinoblastoma In Vivo by Decreasing Angiogenesis and Inducing Apoptosis
Theodoropoulou, S., Brodowska, K., Kayama, M., Morizane, Y., Miller, J. W., Gragoudas, E. S., & Vavvas, D. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052852 · Cited by 50
Activation of AKT pathway by Nrf2/PDGFA feedback loop contributes to HCC progression
Liu, D., Zhang, Y., Wei, Y., Liu, G., Liu, Y., Gao, Q., Zou, L., Zeng, W., & Zhang, N. (2016) · Oncotarget · doi:10.18632/oncotarget.11700 · Cited by 47
The molecular mechanism of the anticancer effect of Artonin E in MDA-MB 231 triple negative breast cancer cells
Etti, I. C., Abdullah, R., Kadir, A. A., Hashim, N. M., Yeap, S. K., Imam, M. U., Ramli, F. B., Malami, I., Lam, K. L., Etti, U., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182357 · Cited by 47
Effects of Ferroportin-Mediated Iron Depletion in Cells Representative of Different Histological Subtypes of Prostate Cancer
Deng, Z., Manz, D. H., Torti, S. V., & Torti, F. M. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7023 · Cited by 47
MicroRNA-411 Downregulation Enhances Tumor Growth by Upregulating MLLT11 Expression in Human Bladder Cancer
Jin, H., Sun, W., Zhang, Y., Yan, H., Liufu, H., Wang, S., Chen, C., Gu, J., Hua, X., Zhou, L., et al. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.03.003 · Cited by 47
LncRNA SOX21-AS1 is associated with progression of hepatocellular carcinoma and predicts prognosis through epigenetically silencing p21
Wei, C., Wang, H., Xu, F., Liu, Z., & Jiang, R. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.05.010 · Cited by 47
Low-dose calcipotriol can elicit wound closure, anti-microbial, and anti-neoplastic effects in epidermolysis bullosa keratinocytes
Guttmann‐Gruber, C., Tockner, B., Scharler, C., Hüttner, C., Common, J., Tay, A. S. L., Denil, S. L. I. J., Klausegger, A., Trost, A., Breitenbach, J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-31823-6 · Cited by 47

Authors: Abbas, T., & Dutta, A.
Affiliations: University of Virginia (US)
Corresponding author: Abbas, Tarek
Dutta, Anindya
ORCID: Abbas, Tarek
Dutta, Anindya
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2009-05-14
Volume: 9
Issue: 6
Pages: 400-414
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc2657
PMC: PMC2722839
OpenAlex: W2162262059
Cited by: 2,712
References: 236
Citations by year: 2026: 99 · 2025: 156 · 2024: 161 · 2023: 206 · 2022: 182 · 2021: 205 · 2020: 204 · 2019: 180 · 2018: 191 · 2017: 196 · 2016: 148 · 2015: 160 · 2014: 142 · 2013: 151 · 2012: 122
FWCI: 9.54
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
National Cancer Institute (R01CA089406, R01 CA 89406, T32CA009109)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords: p21, cyclin-dependent kinase inhibitors, cell cycle arrest, therapeutic target, cell transformation
MeSH terms: Animals, Cell Cycle, Humans, Neoplasms, Tumor Suppressor Protein p53, Cyclin-Dependent Kinase Inhibitor p21

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

p21 in cancer: intricate networks and multiple activities

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks